Neither do phase 3 clinical trials, like the one that produced these results or the next one that needs done. Pharm’s economics are fucked - “but why don’t they just make drugs at cost” is hopelessly naive. This is a new class of drug. The manufacturing costs are among the smallest cost drivers
all right, I'll bite. How much did it cost? just for this drug. how much did the research cost? since you are talking like you know, I'll be the chinhands ingenue and ask you to explain.
lol, they made billions in profit last year. The NIH provided funding more almost all of the new drugs that came to market. How about you provide some actual evidence to back that statement. The NIH does provide significant funding already jamanetwork.com/journals/jam...
Explore the latest in national and global health policy, including health care pricing, delivery, access, quality, safety, equity, and reform.
"Why don't they make drugs at cost" isn't hopelessly naive, it's just another example of why healthcare shouldn't be a commodity